Gevo to Report Third Quarter 2025 Financial Results on November 10, 2025

Stock Information for Alterity Therapeutics Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Alterity Therapeutics Limited

Gevo Reports Third Quarter 2025 Financial Results
Gevo North Dakota Sells Its Remaining 2025 45Z Production Tax Credits for $30 Million, Bringing the Contracted Total for the Year to $52 Million
Gevo Completes Sale of Luverne, Minnesota, Ethanol Facility to A.E. Innovation, Retains Isobutanol Assets for Future Innovation
Gevo Makes First Delivery of Certified Carbon Credits to Biorecro, Unlocking Value from Carbon as a Co-Product
11 Company Presentations Today at The MicroCap Rodeo Conference
Gevo to Present at the MicroCap Rodeo Conference
Frontier Infrastructure, in Collaboration with Gevo and Verity, Launches Complete Carbon Management Platform for Ethanol Industry
Gevo Executes Deal with Biorecro to Accelerate Multi-Year Carbon Credit Offtake and Business Expansion

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.